跳到主要导航 跳到搜索 跳到主要内容

The metabolism of CYP2C9 and CYP2C19 for gliclazide by homology modeling and docking study

  • Yuan Yao
  • , Wei Wei Han
  • , Yi Han Zhou
  • , Ze Sheng Li*
  • , Qiang Li
  • , Xiao Yan Chen
  • , Da Fang Zhong
  • *此作品的通讯作者
  • Jilin University
  • CAS - Shanghai Institute of Materia Medica

科研成果: 期刊稿件 › 文章 › 同行评审

摘要

With homology modeling techniques, a 3D structure model of CYP2C19 was built and refined with molecular mechanics and molecular dynamics simulations. The refined model was assessed to be reasonable by Profile-3D and PROCHECK programs. With the aid of the automatic molecular docking, one substrate and two inhibitors were docked to CYP2C19 by InsightII/Affinity program. The docking results, which are in well agreement with the reported results, demonstrate that the refined model of CYP2C19 is reliable. Then, with the refined model of CYP2C19 and the crystal structure of CYP2C9, the metabolisms of them for gliclazide in two different metabolic pathways were studied and the results show that both enzymes have more favorable interaction energies and stronger affinity with gliclazide in methylhydroxylation pathway than in 6β-hydroxylation pathway. It is exciting that substrate inhibition phenomenon can be found in metabolisms of CYP2C9 and CYP2C19 for gliclazide in two metabolic pathways. Gliclazide can change the conformation of the active sites and decrease obviously the affinities between gliclazide in the active site and enzymes when it is docked in the second active sites in CYP2C9 and CYP2C19. These results are in well agreement with the kinetic experimental results.

源语言英语
页(从-至)854-861
页数8
期刊European Journal of Medicinal Chemistry
卷44
期2
DOI
出版状态已出版 - 2月 2009
已对外发布是

学术指纹

探究 'The metabolism of CYP2C9 and CYP2C19 for gliclazide by homology modeling and docking study' 的科研主题。它们共同构成独一无二的学术指纹。

引用此